Aledie Navas-Nazario1, Fang Yong Li2, Veronika Shabanova2, Pnina Weiss1, David E C Cole3, Thomas O Carpenter4, Alia Bazzy-Asaad5. 1. Section of Respiratory Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut. 2. Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut. 3. Departments of Laboratory Medicine and Pathobiology, Medicine, and Genetics, University of Toronto, Toronto, Ontario, Canada. 4. Section of Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut. 5. Section of Respiratory Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut. Electronic address: alia.bazzy-asaad@yale.edu.
Abstract
BACKGROUND: Potential vitamin D-related influences on inflammatory diseases such as asthma are controversial, including the suggestion that vitamin D insufficiency is associated with increased asthma morbidity. Vitamin D-binding protein transports vitamin D metabolites in the circulation. Single nucleotide polymorphisms in the GC gene encoding vitamin D-binding protein are associated with circulating vitamin D metabolite levels in healthy infants and toddlers. OBJECTIVE: To test the hypothesis that GC single nucleotide polymorphisms encoding the D432E and T436K variants predict subsequent development of asthma in healthy children. METHODS: A retrospective medical record review was performed to determine the development of asthma in 776 children in whom GC genotype, vitamin D-binding protein concentration, and circulating 25-hydroxyvitamin D had been determined at 6 to 36 months of age. Demographic and detailed current clinical data were collected and criteria for asthma were recorded. RESULTS: GC genotype was available for 463 subjects. After an initial analysis of all subject data, the analysis was limited to the predominant Hispanic population (72.1%) to minimize potential confounding effects of ethnicity. Asthma was diagnosed in 87 children (26%). Subjects with the GC genotype encoding the ET/ET (Gc1s/Gc1s) variant had lower odds of developing asthma, representing a protective effect compared with subjects with the DT/DT (Gc1f/Gc1f) variant. CONCLUSION: In the Hispanic population of inner-city New Haven, Connecticut, the ET/ET (Gc1s/Gc1s) genotype of vitamin D-binding protein might confer protection against the development of asthma compared with the wild-type genotype DT/DT (Gc1f/Gc1f).
BACKGROUND: Potential vitamin D-related influences on inflammatory diseases such as asthma are controversial, including the suggestion that vitamin Dinsufficiency is associated with increased asthma morbidity. Vitamin D-binding protein transports vitamin D metabolites in the circulation. Single nucleotide polymorphisms in the GC gene encoding vitamin D-binding protein are associated with circulating vitamin D metabolite levels in healthy infants and toddlers. OBJECTIVE: To test the hypothesis that GC single nucleotide polymorphisms encoding the D432E and T436K variants predict subsequent development of asthma in healthy children. METHODS: A retrospective medical record review was performed to determine the development of asthma in 776 children in whom GC genotype, vitamin D-binding protein concentration, and circulating 25-hydroxyvitamin D had been determined at 6 to 36 months of age. Demographic and detailed current clinical data were collected and criteria for asthma were recorded. RESULTS: GC genotype was available for 463 subjects. After an initial analysis of all subject data, the analysis was limited to the predominant Hispanic population (72.1%) to minimize potential confounding effects of ethnicity. Asthma was diagnosed in 87 children (26%). Subjects with the GC genotype encoding the ET/ET (Gc1s/Gc1s) variant had lower odds of developing asthma, representing a protective effect compared with subjects with the DT/DT (Gc1f/Gc1f) variant. CONCLUSION: In the Hispanic population of inner-city New Haven, Connecticut, the ET/ET (Gc1s/Gc1s) genotype of vitamin D-binding protein might confer protection against the development of asthma compared with the wild-type genotype DT/DT (Gc1f/Gc1f).
Authors: Lei Fu; Francisco Yun; Marko Oczak; Betty Y L Wong; Reinhold Vieth; David E C Cole Journal: Clin Biochem Date: 2009-03-18 Impact factor: 3.281
Authors: John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: M Erkkola; M Kaila; B I Nwaru; C Kronberg-Kippilä; S Ahonen; J Nevalainen; R Veijola; J Pekkanen; J Ilonen; O Simell; M Knip; S M Virtanen Journal: Clin Exp Allergy Date: 2009-06 Impact factor: 5.018
Authors: Elizabeth Ramos-Lopez; Patrick Brück; Thomas Jansen; Jürgen Herwig; Klaus Badenhoop Journal: Diabetes Metab Res Rev Date: 2007-11 Impact factor: 4.876
Authors: Carlos A Camargo; Sheryl L Rifas-Shiman; Augusto A Litonjua; Janet W Rich-Edwards; Scott T Weiss; Diane R Gold; Ken Kleinman; Matthew W Gillman Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Ann-Marie Malby Schoos; Cecilie Vinther; Sarah Nørgaard; Nicklas Brustad; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard; Bo Lund Chawes Journal: Children (Basel) Date: 2019-10-21
Authors: K E Joung; H H Burris; L J Van Marter; T F McElrath; Z Michael; P Tabatabai; A A Litonjua; S T Weiss; H Christou Journal: J Perinatol Date: 2016-07-28 Impact factor: 2.521